Live feed
·
INSIDERFiling
Sutro Biopharma Inc. logo

Chief Executive Officer Chung Jane converted options into 10,938 shares and covered exercise/tax liability with 4,050 shares, increasing direct ownership by 50% to 20,779 units (SEC Form 4)